Adaptive Biotechnologies Corp
NASDAQ:ADPT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
US |
|
A
|
AT Semicon Co Ltd
KOSDAQ:089530
|
KR |
|
T
|
Techno Medica Co Ltd
TSE:6678
|
JP |
|
Aclarion Inc
NASDAQ:ACON
|
US |
|
R1 RCM Holdco Inc
F:6HL0
|
US |
|
I
|
Incon Co Ltd
KOSDAQ:083640
|
KR |
|
D
|
Dongwoo Farm To Table Co Ltd
KOSDAQ:088910
|
KR |
|
O
|
Overseas Shipholding Group Inc
F:19O
|
US |
|
C
|
Casa Systems Inc
F:6CS
|
US |
Wall Street
Price Targets
ADPT Price Targets Summary
Adaptive Biotechnologies Corp
According to Wall Street analysts, the average 1-year price target for
ADPT
is 21.27 USD
with a low forecast of 20.2 USD and a high forecast of 23.1 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ADPT's stock price target?
Price Target
21.27
USD
According to Wall Street analysts, the average 1-year price target for
ADPT
is 21.27 USD
with a low forecast of 20.2 USD and a high forecast of 23.1 USD.
What is Adaptive Biotechnologies Corp's Revenue forecast?
Projected CAGR
15%
For the last 7 years the
compound annual growth rate for
Adaptive Biotechnologies Corp's revenue is
26%.
The projected
CAGR
for the next 3 years is
15%.
